Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2016

29.01.2016 | Original Paper

Electromagnetic interference in implantable cardioverter defibrillators: present but rare

verfasst von: Gesa von Olshausen, Ina-Christine Rondak, Carsten Lennerz, Verena Semmler, Christian Grebmer, Tilko Reents, Sonia Ammar-Busch, Alessandra Buiatti, Felix Bourier, Isabel Deisenhofer, Christof Kolb

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Electromagnetic interference (EMI) with implantable cardioverter defibrillators (ICDs) can cause oversensing and subsequently inappropriate ICD therapies. We retrospectively investigated the current incidence and clinical relevance of oversensing related EMI in a large cohort of ICD patients.

Methods

From January 2005 to April 2013, all ICD interrogations performed at our institution were analyzed for the occurrence of oversensing related EMI. EMI episodes were classified as clinically significant, potentially significant or of minor significance. To identify risk factors for EMI, we also analyzed different lead models in our cohort (integrated vs true bipolar leads).

Results

Data of 2940 ICD patients (mean age 63 ± 16 years, 2322 male patients, 7772 patient-years) were retrospectively analyzed for the occurrence of EMI. During the observation period, a total of 145 (hospital environment n = 97, non-hospital environment n = 48) episodes occurred and resulted in an overall EMI incidence, i.e. event rate, of 1.87 % per patient per year. Focusing on clinically significant or potentially significant episodes, the EMI incidence was 0.27 % per patient per year. Cox proportional hazards regression analysis did not reveal a statistically significant higher hazard of oversensing for patients with integrated bipolar leads compared to patients with true bipolar leads (HR = 2.21; 95 % CI 0.90–5.39; p = 0.083).

Conclusions

Our data demonstrate that EMI continues to occur in everyday life. Patients should be well informed about the potential sources and risks of EMI but they need not be overly concerned since the risk of EMI—especially in a non-hospital environment—is low.
Literatur
1.
Zurück zum Zitat Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940. doi:10.1056/NEJM199612263352601 CrossRefPubMed Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940. doi:10.​1056/​NEJM199612263352​601 CrossRefPubMed
2.
Zurück zum Zitat Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial I (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237. doi:10.1056/NEJMoa043399 CrossRefPubMed Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial I (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237. doi:10.​1056/​NEJMoa043399 CrossRefPubMed
3.
Zurück zum Zitat Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy P, Defibrillation in Heart Failure I (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150. doi:10.1056/NEJMoa032423 CrossRefPubMed Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy P, Defibrillation in Heart Failure I (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150. doi:10.​1056/​NEJMoa032423 CrossRefPubMed
4.
Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice G, American Association for Thoracic S, Society of Thoracic S (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117:e350–e408. doi: 10.1161/CIRCUALTIONAHA.108.189742 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice G, American Association for Thoracic S, Society of Thoracic S (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117:e350–e408. doi: 10.​1161/​CIRCUALTIONAHA.​108.​189742
5.
Zurück zum Zitat Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D (2014) Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail 2:611–619. doi:10.1016/j.jchf.2014.05.015 CrossRefPubMed Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D (2014) Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail 2:611–619. doi:10.​1016/​j.​jchf.​2014.​05.​015 CrossRefPubMed
6.
Zurück zum Zitat Shah H, Mezu U, Patel D, Flanigan S, Hreybe H, Adelstein E, Jain S, Lang V, Saba S (2013) Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients. Pacing Clin Electrophysiol 36:547–552. doi:10.1111/pace.12101 CrossRefPubMed Shah H, Mezu U, Patel D, Flanigan S, Hreybe H, Adelstein E, Jain S, Lang V, Saba S (2013) Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients. Pacing Clin Electrophysiol 36:547–552. doi:10.​1111/​pace.​12101 CrossRefPubMed
7.
Zurück zum Zitat Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115:2474–2480. doi:10.1161/CIRCULATIONAHA.106.663807 CrossRefPubMed Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115:2474–2480. doi:10.​1161/​CIRCULATIONAHA.​106.​663807 CrossRefPubMed
9.
Zurück zum Zitat Rauwolf T, Guenther M, Hass N, Schnabel A, Bock M, Braun MU, Strasser RH (2007) Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions. Europace 9:1041–1047. doi:10.1093/europace/eum195 CrossRefPubMed Rauwolf T, Guenther M, Hass N, Schnabel A, Bock M, Braun MU, Strasser RH (2007) Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions. Europace 9:1041–1047. doi:10.​1093/​europace/​eum195 CrossRefPubMed
10.
Zurück zum Zitat Occhetta E, Bortnik M, Magnani A, Francalacci G, Marino P (2006) Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias. Europace 8:863–869. doi:10.1093/europace/eul093 CrossRefPubMed Occhetta E, Bortnik M, Magnani A, Francalacci G, Marino P (2006) Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias. Europace 8:863–869. doi:10.​1093/​europace/​eul093 CrossRefPubMed
12.
Zurück zum Zitat Pinski SL, Trohman RG (2002) Interference in implanted cardiac devices, Part I. Pacing Clin Electrophysiol 25:1367–1381CrossRefPubMed Pinski SL, Trohman RG (2002) Interference in implanted cardiac devices, Part I. Pacing Clin Electrophysiol 25:1367–1381CrossRefPubMed
13.
Zurück zum Zitat Pinski SL, Trohman RG (2002) Interference in implanted cardiac devices, part II. Pacing Clin Electrophysiol 25:1496–1509CrossRefPubMed Pinski SL, Trohman RG (2002) Interference in implanted cardiac devices, part II. Pacing Clin Electrophysiol 25:1496–1509CrossRefPubMed
14.
15.
16.
Zurück zum Zitat Fernengel A, Schwer C, Helber U, Dornberger V (2007) Inappropriate implantable cardioverter-defibrillator shock induced by electromagnetic interference while taking a shower. Clin Res Cardiol 96:393–395. doi:10.1007/s00392-007-0514-z CrossRefPubMed Fernengel A, Schwer C, Helber U, Dornberger V (2007) Inappropriate implantable cardioverter-defibrillator shock induced by electromagnetic interference while taking a shower. Clin Res Cardiol 96:393–395. doi:10.​1007/​s00392-007-0514-z CrossRefPubMed
17.
18.
19.
Zurück zum Zitat Buiatti A, Pavaci H, Deisenhofer I, Kolb C (2013) Electromagnetic interference between a three-dimensional cardiac mapping system and an implantable cardioverter defibrillator. Clin Res Cardiol 102:781–783. doi:10.1007/s00392-013-0604-z CrossRefPubMed Buiatti A, Pavaci H, Deisenhofer I, Kolb C (2013) Electromagnetic interference between a three-dimensional cardiac mapping system and an implantable cardioverter defibrillator. Clin Res Cardiol 102:781–783. doi:10.​1007/​s00392-013-0604-z CrossRefPubMed
20.
Zurück zum Zitat Hours M, Khati I, Hamelin J (2013) Interference between active implanted medical devices and electromagnetic field emitting devices is rare but Real: results of an Incidence Study in a Population of Physicians in France. Pacing Clin Electrophysiol 37:290–296. doi:10.1111/pace.12269 CrossRefPubMed Hours M, Khati I, Hamelin J (2013) Interference between active implanted medical devices and electromagnetic field emitting devices is rare but Real: results of an Incidence Study in a Population of Physicians in France. Pacing Clin Electrophysiol 37:290–296. doi:10.​1111/​pace.​12269 CrossRefPubMed
21.
Zurück zum Zitat Kolb C, Zrenner B, Schmitt C (2001) Incidence of electromagnetic interference in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 24:465–468CrossRefPubMed Kolb C, Zrenner B, Schmitt C (2001) Incidence of electromagnetic interference in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 24:465–468CrossRefPubMed
22.
Zurück zum Zitat Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, Investigators M-RT (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283. doi:10.1056/NEJMoa1211107 CrossRefPubMed Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, Investigators M-RT (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283. doi:10.​1056/​NEJMoa1211107 CrossRefPubMed
23.
Zurück zum Zitat Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C (2014) Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol 25:52–59. doi:10.1111/jce.12273 CrossRefPubMed Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C (2014) Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol 25:52–59. doi:10.​1111/​jce.​12273 CrossRefPubMed
24.
Zurück zum Zitat Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A (2013) Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 309:1903–1911. doi:10.1001/jama.2013.4598 CrossRefPubMed Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A (2013) Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 309:1903–1911. doi:10.​1001/​jama.​2013.​4598 CrossRefPubMed
25.
Zurück zum Zitat Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA, 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S, Document R (2015) 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing: developed in partnership with and endorsed by the European Heart Rhythm Association (EHRA), the Asia Pacific Heart Rhythm Society (APHRS), and the Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)-Latin American Society of Cardiac Pacing and Electrophysiology. Endorsed by the American College of Cardiology (ACC) and American Heart Association (AHA). Europace (Epub ahead of print). doi: 10.1093/europace/euv411 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA, 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S, Document R (2015) 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing: developed in partnership with and endorsed by the European Heart Rhythm Association (EHRA), the Asia Pacific Heart Rhythm Society (APHRS), and the Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)-Latin American Society of Cardiac Pacing and Electrophysiology. Endorsed by the American College of Cardiology (ACC) and American Heart Association (AHA). Europace (Epub ahead of print). doi: 10.​1093/​europace/​euv411
27.
Zurück zum Zitat Kolb C, Schmieder S, Lehmann G, Zrenner B, Karch MR, Plewan A, Schmitt C (2003) Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol 41:2054–2059CrossRefPubMed Kolb C, Schmieder S, Lehmann G, Zrenner B, Karch MR, Plewan A, Schmitt C (2003) Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol 41:2054–2059CrossRefPubMed
28.
Zurück zum Zitat Jilek C, Tzeis S, Vrazic H, Semmler V, Andrikopoulos G, Reents T, Fichtner S, Ammar S, Rassias I, Theodorakis G, Weber S, Hessling G, Deisenhofer I, Kolb C (2011) Safety of screening procedures with hand-held metal detectors among patients with implanted cardiac rhythm devices: a cross-sectional analysis. Ann Intern Med 155:587–592. doi:10.7326/0003-4819-155-9-201111010-00005 CrossRefPubMed Jilek C, Tzeis S, Vrazic H, Semmler V, Andrikopoulos G, Reents T, Fichtner S, Ammar S, Rassias I, Theodorakis G, Weber S, Hessling G, Deisenhofer I, Kolb C (2011) Safety of screening procedures with hand-held metal detectors among patients with implanted cardiac rhythm devices: a cross-sectional analysis. Ann Intern Med 155:587–592. doi:10.​7326/​0003-4819-155-9-201111010-00005 CrossRefPubMed
29.
30.
Zurück zum Zitat Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B, North American Society of P, Electrophysiology Practice Guideline C (2001) Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med 161:649–655CrossRef Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B, North American Society of P, Electrophysiology Practice Guideline C (2001) Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med 161:649–655CrossRef
32.
Zurück zum Zitat Gifford J, Larimer K, Thomas C, May P, Stanhope S, Gami A (2014) Randomized controlled trial of perioperative ICD management: magnet application versus reprogramming. Pacing Clin Electrophysiol 37:1219–1224. doi:10.1111/pace.12417 CrossRefPubMed Gifford J, Larimer K, Thomas C, May P, Stanhope S, Gami A (2014) Randomized controlled trial of perioperative ICD management: magnet application versus reprogramming. Pacing Clin Electrophysiol 37:1219–1224. doi:10.​1111/​pace.​12417 CrossRefPubMed
33.
Zurück zum Zitat Healey JS, Merchant R, Simpson C, Tang T, Beardsall M, Tung S, Fraser JA, Long L, van Vlymen JM, Manninen P, Ralley F, Venkatraghavan L, Yee R, Prasloski B, Sanatani S, Philippon F, Canadian Cardiovascular S, Canadian Anesthesiologists S, Canadian Heart Rhythm S (2012) Canadian Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol 28:141–151. doi:10.1016/j.cjca.2011.08.121 CrossRefPubMed Healey JS, Merchant R, Simpson C, Tang T, Beardsall M, Tung S, Fraser JA, Long L, van Vlymen JM, Manninen P, Ralley F, Venkatraghavan L, Yee R, Prasloski B, Sanatani S, Philippon F, Canadian Cardiovascular S, Canadian Anesthesiologists S, Canadian Heart Rhythm S (2012) Canadian Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol 28:141–151. doi:10.​1016/​j.​cjca.​2011.​08.​121 CrossRefPubMed
34.
Zurück zum Zitat Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson TB Jr, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A (2011) The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 8:1114–1154. doi:10.1016/j.hrthm.2010.12.023 CrossRefPubMed Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson TB Jr, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A (2011) The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 8:1114–1154. doi:10.​1016/​j.​hrthm.​2010.​12.​023 CrossRefPubMed
35.
Zurück zum Zitat Powell BD, Asirvatham SJ, Perschbacher DL, Jones PW, Cha YM, Cesario DA, Cao M, Gilliam FR 3rd, Saxon LA (2012) Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study. Pacing Clin Electrophysiol 35:863–869. doi:10.1111/j.1540-8159.2012.03407.x CrossRefPubMed Powell BD, Asirvatham SJ, Perschbacher DL, Jones PW, Cha YM, Cesario DA, Cao M, Gilliam FR 3rd, Saxon LA (2012) Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study. Pacing Clin Electrophysiol 35:863–869. doi:10.​1111/​j.​1540-8159.​2012.​03407.​x CrossRefPubMed
36.
Zurück zum Zitat Weretka S, Michaelsen J, Becker R, Karle CA, Voss F, Hilbel T, Osswald BR, Bahner ML, Senges JC, Kuebler W, Schoels W (2003) Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 26:65–70CrossRefPubMed Weretka S, Michaelsen J, Becker R, Karle CA, Voss F, Hilbel T, Osswald BR, Bahner ML, Senges JC, Kuebler W, Schoels W (2003) Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 26:65–70CrossRefPubMed
Metadaten
Titel
Electromagnetic interference in implantable cardioverter defibrillators: present but rare
verfasst von
Gesa von Olshausen
Ina-Christine Rondak
Carsten Lennerz
Verena Semmler
Christian Grebmer
Tilko Reents
Sonia Ammar-Busch
Alessandra Buiatti
Felix Bourier
Isabel Deisenhofer
Christof Kolb
Publikationsdatum
29.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-0965-1

Weitere Artikel der Ausgabe 8/2016

Clinical Research in Cardiology 8/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.